A
Amin Al-Ahmad
Researcher at Tufts Medical Center
Publications - 160
Citations - 3818
Amin Al-Ahmad is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Catheter ablation & Atrial fibrillation. The author has an hindex of 22, co-authored 160 publications receiving 3025 citations. Previous affiliations of Amin Al-Ahmad include Tufts University.
Papers
More filters
Journal ArticleDOI
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.
Amin Al-Ahmad,William M. Rand,Guruprasad Manjunath,Marvin A. Konstam,Deeb N. Salem,Andrew S. Levey,Mark J. Sarnak +6 more
TL;DR: Lower GFR and hematocrit were associated with a higher prevalence of traditional cardiovascular risk factors and decreased kidney function and anemia are risk factors for all-cause mortality in patients with LV dysfunction.
Journal ArticleDOI
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Deeb N. Salem,Paul D. Stein,Amin Al-Ahmad,Henry I. Bussey,Dieter Horstkotte,Nancy Miller,Stephen G. Pauker +6 more
TL;DR: In this article, the authors presented the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines for Rheumatic mitral valve disease and atrial fibrillation (AF), or a history of previous systemic embolism.
Journal ArticleDOI
Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial
Luigi Di Biase,J. David Burkhardt,Prasant Mohanty,Sanghamitra Mohanty,Javier Sanchez,Chintan Trivedi,Mahmut F. Güneş,Yalçın Gökoğlan,Carola Gianni,Rodney Horton,Sakis Themistoclakis,G. Joseph Gallinghouse,Shane Bailey,Jason Zagrodzky,Richard Hongo,Salwa Beheiry,Pasquale Santangeli,Michela Casella,Antonio Russo,Amin Al-Ahmad,Patrick Hranitzky,Dhanunjaya Lakkireddy,Claudio Tondo,Andrea Natale +23 more
TL;DR: This randomized study showed that both after a single procedure and after redo procedures in patients with LSPAF, empirical electrical isolation of the LAA improved long-term freedom from atrial arrhythmias without increasing complications.
Journal ArticleDOI
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial
Luigi Di Biase,J. David Burkhardt,Dhanujaya Lakkireddy,Corrado Carbucicchio,Sanghamitra Mohanty,Prasant Mohanty,Chintan Trivedi,Pasquale Santangeli,Pasquale Santangeli,Rong Bai,Giovanni B. Forleo,Rodney Horton,Shane Bailey,Javier Sanchez,Amin Al-Ahmad,Patrick Hranitzky,G. Joseph Gallinghouse,Gemma Pelargonio,Richard Hongo,Salwa Beheiry,Steven Hao,Madhu Reddy,Antonio Rossillo,Sakis Themistoclakis,Antonio Russo,Michela Casella,Claudio Tondo,Andrea Natale +27 more
TL;DR: An extensive substrate-based ablation approach is superior to ablation targeting only clinical and stable VTs in patients with ischemic cardiomyopathy presenting with tolerated VT.
Journal ArticleDOI
Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
Luigi Di Biase,Dhanujaya Lakkireddy,Chintan Trivedi,T. Deneke,Martin Martinek,Sanghamitra Mohanty,Prasant Mohanty,Sameer Prakash,Rong Bai,Madhu Reddy,Carola Gianni,Rodney Horton,Shane Bailey,Elisabeth Sigmund,Michael Derndorfer,Anja Schade,Patrick Mueller,Atilla Szoelloes,Javier Sanchez,Amin Al-Ahmad,Patrick Hranitzky,G. Joseph Gallinghouse,Richard Hongo,Salwa Beheiry,Helmut Pürerfellner,J. David Burkhardt,Andrea Natale +26 more
TL;DR: Uninterrupted apixaban administration in patients undergoing AF ablation seems to be feasible and effective in preventing clinical and silent thromboembolic events without increasing the risk of major bleeding.